<?xml version="1.0" encoding="UTF-8"?>
<results title="tropicalVirus">
 <result pre="diseases discussed in this Review. Disease Vaccine Highest discovery status" exact="Dengue" post="CYD-TDV/Dengvaxia: Efficacy 60%–70%, but only given to persons with"/>
 <result pre="immunity and for manipulating it to tackle life-threatening fungal infections." exact="Dengue" post="Dengue fever is a mosquito-borne viral infection found in"/>
 <result pre="and for manipulating it to tackle life-threatening fungal infections. Dengue" exact="Dengue" post="fever is a mosquito-borne viral infection found in tropical"/>
 <result pre="virus, and all serotypes are presently circulating in endemic areas." exact="DENV" post="infects cells of the human immune system and other"/>
 <result pre="in domain II showed strong neutralizing activity against all 4" exact="DENV" post="serotypes [46]. However, at subneutralizing concentrations, it also elicited"/>
 <result pre="PeerJ. 2017;5:e402110.7717/peerj.402129152418 49SimmonsM, PutnakR, SunP, BurgessT, MarascoWA. Antibody Prophylaxis Against" exact="Dengue" post="Virus 2 Infection in Non-Human Primates. Am J Trop"/>
 <result pre=".26475445 122AguiarM, StollenwerkN, HalsteadSB. The Impact of the Newly Licensed" exact="Dengue" post="Vaccine in Endemic Countries. PLoS Negl Trop Dis. 2016;10(12):e000517910.1371/journal.pntd.000517928002420"/>
 <result pre="infection in primate leukocytes. Nature. 1977;265(5596):739–41. 10.1038/265739a0 .404559 124collab: Live" exact="Dengue" post="Vaccines Technical Consultation Reporting G, Bentsi-EnchillAD, SchmitzJ, EdelmanR, DurbinA,"/>
</results>
